newsfilter
← Latest News
GlobeNewswire·

Amryt Receives Reimbursement Approval from the Dutch Ministry of Health for Myalepta® (metreleptin)

Amryt Receives Reimbursement Approval from the Dutch Ministry of Health for Myalepta® (metreleptin) DUBLIN, Ireland, and Boston MA, October 17, 2022, Amryt (NASDAQ:AMYT), a global, commercial-stage